Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Open Modification Searching of SARS-CoV-2-Human Protein Interaction Data Reveals Novel Viral Modification Sites. | Mol Cell Proteomics | 2022 | 36241021 | PubTator, text mining | PubMed |
| Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. | J Clin Med | 2022 | 36233559 | PubTator, text mining | PubMed |
| Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies. | Int J Mol Sci | 2022 | 36233160 | PubTator, text mining | PubMed |
| Direct Interaction of Coronavirus Nonstructural Protein 3 with Melanoma Differentiation-Associated Gene 5 Modulates Type I Interferon Response during Coronavirus Infection. | Int J Mol Sci | 2022 | 36232993 | PubTator, text mining | PubMed |
| Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability. | Int J Mol Sci | 2022 | 36232570 | PubTator, text mining | PubMed |
| Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development. | Int J Mol Sci | 2022 | 36232307 | PubTator, text mining | PubMed |
| Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus. | Curr Opin Immunol | 2022 | 36215931 | PubTator, text mining | PubMed |
| Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies. | Can J Infect Dis Med Microbiol | 2022 | 36199815 | PubTator, text mining | PubMed |
| Sneaking into the viral safe-houses: Implications of host components in regulating integrity and dynamics of rotaviral replication factories. | Front Cell Infect Microbiol | 2022 | 36189370 | PubTator, text mining | PubMed |
| Regulation of cGAS/STING signaling and corresponding immune escape strategies of viruses. | Front Cell Infect Microbiol | 2022 | 36189363 | PubTator, text mining | PubMed |
| Genomic and evolutionary characteristics of G9P[8], the dominant group a rotavirus in China (2016-2018). | Front Microbiol | 2022 | 36187963 | PubTator, text mining | PubMed |
| A genetically encoded BRET-based SARS-CoV-2 Mpro protease activity sensor. | Commun Chem | 2022 | 36187754 | PubTator, text mining | PubMed |
| Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations. | Front Cell Neurosci | 2022 | 36187294 | PubTator, text mining | PubMed |
| SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis. | Commun Biol | 2022 | 36180527 | PubTator, text mining | PubMed |
| Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease. | J Med Chem | 2022 | 36179320 | PubTator, text mining | PubMed |
| Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway. | Microbiol Spectr | 2022 | 36173315 | PubTator, text mining | PubMed |
| Host specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome. | bioRxiv | 2022 | 36172130 | PubTator, text mining | PubMed |
| TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I. | Mol Ther Oncolytics | 2022 | 36159777 | PubTator, text mining | PubMed |
| Omicron variant: Current insights and future directions. | Microbiol Res | 2022 | 36152612 | PubTator, text mining | PubMed |
| Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance. | Transl Psychiatry | 2022 | 36151087 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=39